Neurology 1703 - Neurology Alert - Mar 01, 2013

Target Audience:

This activity is intended for the neurologist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Physician Editor
Matthew Fink, MD
Interim Chair and Neurologist-in-Chief
Department of Neurology and Neuroscience
Weill Cornell Medical College
New York Presbyterian Hospital

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Peer Reviewer
M. Flint Beal, MD
Anne Parrish Titzel Professor
Department of Neurology and Neuroscience
Weill Cornell Medical Center

Assistant Editors
Dana Leifer, MD
Associate Professor of Clinical Neurology
Weill Cornell Medical College

Michael Lin, MD, PhD
Assistant Professor of Neurology and Neurosciences
Weill Cornell Medical College

Michael Rubin, MD, FRCP(C)
Professor of Clinical Neurology;
Specialty area, Neuromuscular Disorders
Weill Cornell Medical College

Bianca D. Santomasso, MD, PhD
Chief Resident in Neurology

Nitin K. Sethi, MD
Assistant Professor of Neurology
Weill Cornell Medical College


  • Endovascular Therapy for Acute Stroke Still of Unproven Benefit: The Quest Continues
  • A Newly Discovered Genetic Cause of Alzheimer's Disease - Mutations of TREM2
  • Autoantibodies to N-methyl-D-aspartate Receptor Found in Some Adults with Herpes Simplex Encephalitis: Are They Significant?
  • Subcutaneous IVIG for Chronic Inflammatory Demyelinating Polyneuropathy
  • Abnormal Thalamocortical Structural and Functional Connectivity in Juvenile Myoclonic Epilepsy


  • discuss current scientific data regarding the diagnosis and treatment of neurological disease
  • discuss the pathogenesis and treatment of pain
  • describe the basic science of brain function
  • discuss new information regarding new drugs for commonly diagnosed neurological conditions

Financial Disclosure:

Neurology Alert's editor in chief, Matthew Fink, MD, is a retained consultant for MAQUET. Peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and managing editor Neill Kimball , Assistant editors Dana Leifer, MD , Michael Lin, MD, PhD , Michael Rubin, MD, FRCP(C), Authors Bianca D. Santomasso, MD, PhD, and Nitin K. Sethi, MD report no financial relationships relevant to this field of study.

Copyright 2013 AHC Media. All rights reserved.